We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Amends Infringement Claims for Copaxone Patents
Teva Amends Infringement Claims for Copaxone Patents
November 24, 2009
Teva Pharmaceutical Industries is seeking to add infringement of three additional patents on its multiple sclerosis drug Copaxone to its infringement claims against Momenta Pharmaceuticals and Sandoz.